96. Crohn disease Clinical trials / Disease details


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04305535
(ClinicalTrials.gov)
February 13, 20205/3/2020Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn DiseaseClinical Trial to Evaluate the Effect of an Oligomeric Oral Nutritional Supplement on the Response in Intestinal Absorption and Inflammation, in Patients With CROHN DiseaseCrohn Disease;Absorption; Disorder, Protein; Disorder; Disorder, Fat; Disorder, Carbohydrate;MalnutritionDietary Supplement: Peptidic+Probiotic;Dietary Supplement: Peptidic+Placebo;Dietary Supplement: Polymeric+PlaceboInstituto de Investigación Sanitaria de la Fundación Jiménez DíazAdventia Pharma, S.L.;Biopolis S.L.Recruiting18 YearsN/AAll162N/ASpain